Improvement of Care & Outcome
Increasing rates of obesity in an aging population are leading to increasing prevalence of diabetes, which is already affecting >10% of the global population. Diabetes healthcare costs are enormous with 966 billion USD spent in 2021, expecting to increase to an astronomical 1.05 trillion USD in 2045. Healthcare use, mainly hospital care, is much higher among people with diabetes (PWDs) compared with people without diabetes. In the Netherlands 1.2 million people are affected by diabetes, costing €1.6 billion in 2016, with €1.3 billion attributed to complications. Not much is known about hospital use on a PWD level. This study, co-authored by Theo Sas of Diabeter, aimed to assess healthcare resource use, hospital expenditure and cost-driving factors among adult PWDs in Dutch hospitals, employing real-world reimbursement data.
In the Netherlands insurance companies receive invoices from hospitals based on ‘diagnosis treatment combinations’ (DTC), which are predefined packages of healthcare services each with their own DTC code, depending on medical specialty, diagnosis and related treatment. Hospitals archive these DTC-invoices. A database with benchmark information from 65 hospitals (88% of all Dutch hospitals) is serviced by LOGEX. Diabetes DBC claims of 193,840 adult PWDs treated in 65 hospitals between 1-1-2019 and 31-12-2019 were analysed.
Key findings:
Concluding, the authors state
Please click here for the PubMed link.